TITLE

MEDAREX/NEURO THERAPEUTICS TO DEVELOP ANTIBODY THERAPEUTICS

PUB. DATE
June 2001
SOURCE
Worldwide Biotech;Jun2001, Vol. 13 Issue 6, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Announces the collaboration of Medarex Inc. with Nuero Therapeutics Inc. to develop a full human antibody therapeutics for central nervous system.
ACCESSION #
4570811

 

Related Articles

  • Bristol-Myers Squibb: Medarex deal won't shift gloomy outlook.  // PharmaWatch: Cancer;December2004, Vol. 3 Issue 12, p15 

    Reports that Bristol-Myers Squibb Co. (BMS) has signed a collaboration agreement with Medarex Inc. to develop oncology drug, MDX-010. Identification of MDX-010 as a human antibody investigational product targeting the CTLA-4 receptor that is already undergoing Phase III trials for the treatment...

  • Medarex and Organon enter research agreement.  // PharmaWatch: Biotechnology;Jul2007, Vol. 6 Issue 7, p14 

    The article reports on the collaboration between Medarex Inc. and Organon International Inc. Medarex has agreed to work jointly with Organon on human antibody therapeutics research for the treatment of cancer and autoimmune disorders. Under the terms of the agreement, the two companies plan to...

  • DIATOS AND MEDAREX SIGN CANCER PRODUCT LICENSING AGREEMENT.  // Worldwide Biotech;Jun2003, Vol. 15 Issue 6, p2 

    Reports on the cancer product licensing agreement signed by Diatos SA and Medarex Inc. in June 2003.

  • Medarex arms the immune system. Rodetis, Susan // Equities;Apr95, Vol. 43 Issue 4, p14 

    Focuses on the company Medarex which was established as a joint venture between Dartmouth Medical School and Essex Chemical. Research on how to combat cancer; Effectiveness of Medarex's product MDX-210 in targeting tumor cells; Partnership with E. Merck; Alliance with French cellular therapy...

  • Medarex Moving Forward With Antibody Developments.  // Chemical Market Reporter;5/28/2001, Vol. 259 Issue 22, p8 

    Focuses on an antibody development center and manufacturing facility opened by Medarex Inc. in Greenwich Township, New Jersey. Capacity of the manufacturing facility; Background of Medarex; Purpose of Medarex in establishing the facility.

  • Distinguished service. Horton, Kathleen // Pharmaceutical Executive;Jul97, Vol. 17 Issue 7, p90 

    Announces the appointment of Irwin Lerner as chairman of biopharmaceutical company Medarex.

  • Private Trade Opportunities.  // Middle East Business Intelligence;1/20/2003, Vol. 21 Issue 2, p8 

    Reports on private trade opportunities in the Middle East, as of January 20, 2003. Information technology equipment venture with ITD Technology Group in Turkey; Port operations venture with Ship & Crew in Egypt.

  • Localization is critical to success in China. Frazee, Valerie // Workforce;Mar98 Supplement Global Workforce, Vol. 77, p8 

    Discusses the prospects of joint ventures in China. Significance of the prompt localization of the enterprise; Cost of the average non-Chinese general manager; Average length of a successful establishment of foreign-owned ventures.

  • Joint venture formed.  // Business Insurance;03/30/98, Vol. 32 Issue 13, p4 

    Reports on the joint venture between Reliance National Insurance Company, Lambert Fenchurch Group P.L.C and MTS Insurance Services. Name of the joint venture; Operations of the company; Contact information.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics